A discovery program for SARS-CoV-2-nABs potentially targeting its resistant strains.
New study reveals flaws in AI tools used for SARS-CoV-2 antibody discovery
- Post author:
- Post published:January 19, 2024
- Post category:uncategorized
Empowering individuals with knowledge, fostering healthier lifestyles, and fostering a community dedicated to diabetes awareness and prevention. Together, we’re shaping a healthier future.
Subscribe To Us
By submitting via this part of the website you are granting us permission to store and process your data according to our Standard privacy policy
© 2024 Diabetes Prevention Awareness Center.